Mid-Term Report Summary - 3PS (3Ps Plastic-Antibodies, Plasmonics and Photovoltaic-Cells: on-site screening of cancer biomarkers made possible)
The work carried out in the context of the Starting Grant 3P’s targets the construction of a device that combines Plastic-Antibodies, Plasmonics and Photovoltaic-Cells technologies, to be applied to on-site screening of cancer biomarkers. Several scientific progresses have been achieved after 30 months of activity, including (i) the design of novel plastic antibodies for several protein cancer biomarkers; (ii) the inclusion of plasmonic particles on a photovoltaic cell to improve the efficiency of the cell; (iii) the selection of conditions that allow the set-up of a highly efficient photovoltaic cell; (iv) a successful set-up combining plastic antibody and photovoltaic cell; (e) and finally an attempt to use alternative materials as electrode support to generate a low cost device. Further studies are being conducted aiming to produce an autonomous device, operated by light and generating information about the amount to cancer biomarkers on biological fluids.
Paula Cristina Ferreira da Silva, (Financial Director)
Numer rekordu: 183587 / Ostatnia aktualizacja: 2016-06-16
Źródło informacji: SESAM